--- Morticia <morticiaw666@...
> We took Spazz to our regular vet on Monday, and that
> is when the
> ultrasound was done, and I was told my lil beautiful
> boy has HCM.
> The vet has given me no hope of him surviving longer
> then 4 months,
> and that is only if this treatment of furosemide,
> diltiazem, and one baby asperin twice a week works
> for him. I even
> called another vet in my area, and had Spazz's
> records faxed to her,
> she phoned me and said she didnt think it would be
> worth the money
> for me to get a second opinion, she thinks my own
> vet has predicted
> Spazz's future pretty accurately.
Since you told me in a private email that you live in
Maine, I looked on the ACVIM website for your state.
No cardiology diplomates, but there are 2 small animal
internal medicine diplomates. ACVIMs are qualified to
treat cardiology, DVMs generally speaking not.
Mason, Gail D. Portland, ME
Bovee, Kenneth C Stonington, ME
Prognosis after a thromboembolism is related to how
well the underlying heart disease is stabilized after
the thrombolytic event.
Drug Therapy of Heart Failure: The Big Picture
Bruce W. Keene, DVM, MS, Diplomate ACVIM (Cardiology)
Dr. Keene explains the rationale for utilizing the
knowledge gained from human CHF trials.
"Historically, drug therapy for heart failure can be
divided into roughly 3 continuous and variably
overlapping eras. Before the 1970's, heart failure
therapy most often consisted of the administration of
a digitalis glycoside and a diuretic. Advances in
understanding the hemodynamic model of heart function
and failure led in the late 1970's to the concept of
afterload reduction, and the first human clinical
trials to show improved survival with vasodilator
therapy followed shortly thereafter. Veterinary use of
vasodilators to treat heart failure roughly paralleled
their usage in human medicine. More recently, drug
therapy designed to interrupt the cascade of
neurohormonal events that accompanies and contributes
to the pathogenesis of heart failure has resulted in
clinically significant improvement in survival as well
as in the quality of life of both human and veterinary
heart failure patients."
The current accepted therapy for human CHF, is a 3
drug regimen (ACE inhibitor, beta blockade and loop
Hope this answers some of your questions.
Do you Yahoo!?
Yahoo! SiteBuilder - Free web site building tool. Try it!